Gregory D. Busse

638 total citations
33 papers, 502 citations indexed

About

Gregory D. Busse is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gregory D. Busse has authored 33 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 12 papers in Cognitive Neuroscience and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gregory D. Busse's work include Attention Deficit Hyperactivity Disorder (16 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Bipolar Disorder and Treatment (6 papers). Gregory D. Busse is often cited by papers focused on Attention Deficit Hyperactivity Disorder (16 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Bipolar Disorder and Treatment (6 papers). Gregory D. Busse collaborates with scholars based in United States, United Kingdom and Australia. Gregory D. Busse's co-authors include Anthony L. Riley, Azmi Nasser, Joseph T. Hull, Tesfaye Liranso, Stefan Schwabe, Fatima Chowdhry, Robert L. Findling, Zare Melyan, Andrew J. Cutler and Jonathan Rubin and has published in prestigious journals such as Neurology, Journal of the American Academy of Child & Adolescent Psychiatry and Psychopharmacology.

In The Last Decade

Gregory D. Busse

33 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory D. Busse United States 14 279 183 178 66 53 33 502
Karin Martins Gomes Brazil 13 273 1.0× 108 0.6× 216 1.2× 56 0.8× 60 1.1× 41 560
Seth H. Blum United States 14 214 0.8× 116 0.6× 247 1.4× 126 1.9× 75 1.4× 23 546
Angela M. Henricks United States 8 204 0.7× 68 0.4× 154 0.9× 115 1.7× 44 0.8× 18 488
Alisa R. Kosheleff United States 12 106 0.4× 112 0.6× 141 0.8× 27 0.4× 69 1.3× 18 304
Anne Tammimäki Finland 12 90 0.3× 122 0.7× 221 1.2× 71 1.1× 215 4.1× 22 578
Eyal Shamir Israel 14 222 0.8× 171 0.9× 75 0.4× 40 0.6× 90 1.7× 21 616
Horst Gann Germany 18 126 0.5× 458 2.5× 186 1.0× 127 1.9× 52 1.0× 35 879
E. Pinto Belgium 10 70 0.3× 108 0.6× 145 0.8× 60 0.9× 46 0.9× 19 458
Annarita Barone Italy 14 189 0.7× 81 0.4× 158 0.9× 30 0.5× 128 2.4× 39 536
Kazuki Honda Japan 13 167 0.6× 236 1.3× 113 0.6× 34 0.5× 43 0.8× 28 555

Countries citing papers authored by Gregory D. Busse

Since Specialization
Citations

This map shows the geographic impact of Gregory D. Busse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory D. Busse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory D. Busse more than expected).

Fields of papers citing papers by Gregory D. Busse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory D. Busse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory D. Busse. The network helps show where Gregory D. Busse may publish in the future.

Co-authorship network of co-authors of Gregory D. Busse

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory D. Busse. A scholar is included among the top collaborators of Gregory D. Busse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory D. Busse. Gregory D. Busse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Downs, Jenny, Peter Jacoby, Nicola Specchio, et al.. (2024). Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial. European Journal of Paediatric Neurology. 51. 140–146. 6 indexed citations
2.
Nasser, Azmi, Roberto Goméni, Gianpiera Ceresoli‐Borroni, et al.. (2024). Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease. Journal of Pharmacokinetics and Pharmacodynamics. 51(4). 385–393. 1 indexed citations
3.
Fitch, William L., Steven M. Smith, Michael S. Saporito, et al.. (2023). Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment. Drug Metabolism and Disposition. 51(6). 753–763. 7 indexed citations
4.
5.
Faraone, Stephen V., Roberto Goméni, Joseph T. Hull, et al.. (2022). Predicting efficacy of viloxazine extended-release treatment in adults with ADHD using an early change in ADHD symptoms: Machine learning Post Hoc analysis of a phase 3 clinical trial. Psychiatry Research. 318. 114922–114922. 13 indexed citations
6.
7.
Faraone, Stephen V., Roberto Goméni, Joseph T. Hull, et al.. (2021). Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trials. Psychiatry Research. 296. 113664–113664. 23 indexed citations
8.
9.
Nasser, Azmi, Tesfaye Liranso, Joseph T. Hull, et al.. (2021). Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial. Clinical Therapeutics. 43(4). 684–700. 39 indexed citations
10.
Nasser, Azmi, Tesfaye Liranso, Joseph T. Hull, et al.. (2021). A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology. 41(4). 370–380. 34 indexed citations
11.
Liranso, Tesfaye, et al.. (2020). Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults. The Journal of Clinical Psychiatry. 81(6). 14 indexed citations
12.
Rinker, Jennifer A., Gregory D. Busse, Peter G. Roma, et al.. (2008). The effects of nicotine on ethanol-induced conditioned taste aversions in Long–Evans rats. Psychopharmacology. 197(3). 409–419. 14 indexed citations
13.
Rinker, Jennifer A., Gregory D. Busse, & Anthony L. Riley. (2007). An assessment of sex differences in nicotine-induced conditioned taste aversions. Pharmacology Biochemistry and Behavior. 88(4). 427–431. 26 indexed citations
14.
Jones, Jane, Gregory D. Busse, & Anthony L. Riley. (2006). Strain-dependent sex differences in the effects of alcohol on cocaine-induced taste aversions. Pharmacology Biochemistry and Behavior. 83(4). 554–560. 20 indexed citations
15.
Busse, Gregory D., et al.. (2005). The effects of cocaine, alcohol and cocaine/alcohol combinations in conditioned taste aversion learning. Pharmacology Biochemistry and Behavior. 82(1). 207–214. 11 indexed citations
16.
Busse, Gregory D., E. Clinton Lawrence, & Anthony L. Riley. (2005). The effects of alcohol preexposure on cocaine, alcohol and cocaine/alcohol place conditioning. Pharmacology Biochemistry and Behavior. 81(3). 459–465. 21 indexed citations
17.
Busse, Gregory D. & Anthony L. Riley. (2004). Cocaine, but not alcohol, reinstates cocaine-induced place preferences. Pharmacology Biochemistry and Behavior. 78(4). 827–833. 9 indexed citations
18.
Busse, Gregory D., et al.. (2003). The modulation of cocaine-induced conditioned place preferences by alcohol: effects of cocaine dose. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(1). 149–155. 26 indexed citations
19.
Busse, Gregory D. & Anthony L. Riley. (2002). Modulation of cocaine-induced place preferences by alcohol. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(7-8). 1373–1381. 14 indexed citations
20.
Kubicki, St., et al.. (1970). EEG in Fatal and Near-Fatal Poisoning with Soporific Drugs I. Typical EEG Patterns. Clinical Electroencephalography. 1(1). 5–13. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Martins Gomes Breakdown of academic impact, for papers by Seth H. Blum Breakdown of academic impact, for papers by Angela M. Henricks Breakdown of academic impact, for papers by Alisa R. Kosheleff Breakdown of academic impact, for papers by Anne Tammimäki Breakdown of academic impact, for papers by Eyal Shamir Breakdown of academic impact, for papers by Horst Gann Breakdown of academic impact, for papers by E. Pinto Breakdown of academic impact, for papers by Annarita Barone Breakdown of academic impact, for papers by Kazuki Honda
Rankless by CCL
2026